Related Experiment Videos
A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys
Abstract:
(-)-9-Nor-9beta-hydroxy-hexahydrocannabinol[(-)-9-nor-9beta-OH-HHC] produced hypotension and bradycardia in anesthetized dogs, was a potent antinociceptive agent in the mouse tail-flick and p-phenylquinone abdominal-stretching tests, but did not reverse the effects of morphine withdrawal in dependent monkeys.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Calcium-41: a technology for monitoring changes in bone mineral.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
A randomized trial of vitamin D₃ supplementation in children: dose-response effects on vitamin D metabolites and calcium absorption.
The Journal of clinical endocrinology and metabolism·2013
Racial differences in cortical bone and their relationship to biochemical variables in Black and White children in the early stages of puberty.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Simple isotopic method using oral stable or radioactive tracers for estimating fractional calcium absorption in adult women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
Validation of a simple isotope method for estimating true calcium fractional absorption in adolescents.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.
The Journal of clinical endocrinology and metabolism·2009
Is heat acclimation able to increase whole-body sensitivity to insulin?
Research communications in chemical pathology and pharmacology·1994
Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats.
Research communications in chemical pathology and pharmacology·1994
Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.
Research communications in chemical pathology and pharmacology·1994
Copper cytotoxicity impairs DNA synthesis but not protein phosphorylation upon growth stimulation in LEC mutant rat.
Research communications in chemical pathology and pharmacology·1994
Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Research communications in chemical pathology and pharmacology·1994
Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Research communications in chemical pathology and pharmacology·1994
Molecular logics in dual sensor regulation of diguanylate cyclase activity-Phosphorylation OR blue-light activation.
Protein science : a publication of the Protein Society·2026
Serendipitous Emergence of Pyrrolo[2,3,4-kl]acridin-1(2H)-one Derivatives: From Unexpected Discovery to Synthetic Development.
Chemical record (New York, N.Y.)·2026
SmI2-mediated tandem cyclization route for stereoselective synthesis of the tetracyclic core of daphenylline.
Organic & biomolecular chemistry·2026
Arylsulfonylaminopyridines as Potential Epac Inhibitors: Design, Synthesis and Effects on Myocardial Strips.
Medicinal chemistry (Shariqah (United Arab Emirates))·2026
Recent Comparative Advances in the Mechanistic Actions and Translational Relevance of Syringic Acid and Vanillic Acid for Oxidative Stress-Associated Disorders.
Recent advances in food, nutrition & agriculture·2026
Herbal Creams in Dermatology: Efficacy, Safety, Formulation, and Regulatory Considerations.
Current pharmaceutical design·2026